Literature DB >> 16291671

Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

John P Hays1, Saskia van Selm, Theo Hoogenboezem, Silvia Estevão, Kimberly Eadie, Peter van Veelen, Jan Tommassen, Alex van Belkum, Peter W M Hermans.   

Abstract

Moraxella catarrhalis is a common commensal of the human respiratory tract that has been associated with a number of disease states, including acute otitis media in children and exacerbations of chronic obstructive pulmonary disease in adults. During studies to investigate the outer membrane proteins of this bacterium, two novel major proteins, of approximately 19 kDa and 16 kDa (named OMP J1 and OMP J2, respectively), were identified. Further analysis indicated that these two proteins possessed almost identical gene sequences, apart from two insertion/deletion events in predicted external loops present within the putative barrel-like structure of the proteins. The development of a PCR screening strategy found a 100% (96/96) incidence for the genes encoding the OMP J1 and OMP J2 proteins within a set of geographically diverse M. catarrhalis isolates, as well as a significant association of OMP J1/OMP J2 with both the genetic lineage and the complement resistance phenotype (Fisher's exact test; P < 0.01). Experiments using two DeltaompJ2 mutants (one complement resistant and the other complement sensitive) indicated that both were less easily cleared from the lungs of mice than were their isogenic wild-type counterparts, with a significant difference in bacterial clearance being observed for the complement-resistant isolate but not for its isogenic DeltaompJ2 mutant (unpaired Student's t test; P < 0.001 and P = 0.32). In this publication, we characterize a novel outer membrane protein of Moraxella catarrhalis which exists in two variant forms associated with particular genetic lineages, and both forms are suggested to contribute to bacterial clearance from the lungs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291671      PMCID: PMC1291255          DOI: 10.1128/JB.187.23.7977-7984.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  43 in total

1.  Biological characterization of an Enterobacter cloacae outer membrane protein (OmpX).

Authors:  J Stoorvogel; M J van Bussel; J A van de Klundert
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

2.  Molecular characterization of an Enterobacter cloacae outer membrane protein (OmpX).

Authors:  J Stoorvogel; M J van Bussel; J Tommassen; J A van de Klundert
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

3.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 4.  Studies of the outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

Review 5.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

6.  Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease.

Authors:  P P Cook; D W Hecht; D R Snydman
Journal:  J Hosp Infect       Date:  1989-04       Impact factor: 3.926

7.  A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.

Authors:  T F Patterson; J E Patterson; B L Masecar; G E Barden; W J Hierholzer; M J Zervos
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

8.  Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.

Authors:  Arne Forsgren; Marta Brant; Kristian Riesbeck
Journal:  J Infect Dis       Date:  2004-06-09       Impact factor: 5.226

9.  Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.

Authors:  B Nicotra; M Rivera; J I Luman; R J Wallace
Journal:  Arch Intern Med       Date:  1986-05

Review 10.  Branhamella catarrhalis respiratory infections.

Authors:  H Hager; A Verghese; S Alvarez; S L Berk
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec
View more
  5 in total

1.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

Review 2.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

3.  Moraxella catarrhalis expresses an unusual Hfq protein.

Authors:  Ahmed S Attia; Jennifer L Sedillo; Wei Wang; Wei Liu; Chad A Brautigam; Wade Winkler; Eric J Hansen
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

4.  Population density profiles of nasopharyngeal carriage of 5 bacterial species in pre-school children measured using quantitative PCR offer potential insights into the dynamics of transmission.

Authors:  Valtyr Thors; Begonia Morales-Aza; Grace Pidwill; Ian Vipond; Peter Muir; Adam Finn
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

5.  Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion.

Authors:  Kim Stol; Suzanne J C Verhaegh; Kees Graamans; Joost A M Engel; Patrick D J Sturm; Willem J G Melchers; Jacques F Meis; Adilia Warris; John P Hays; Peter W M Hermans
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-01-29       Impact factor: 1.675

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.